• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎克雷伯菌肺炎发展为继发性肺炎克雷伯菌血流感染的临床特征、危险因素和结局。

Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.

机构信息

Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.

Department of Intensive Care Unit, Ningbo Fourth Hospital, 291 Donggu Road, Dandong Street, Ningbo, 315700, Zhejiang, China.

出版信息

BMC Pulm Med. 2023 Mar 28;23(1):102. doi: 10.1186/s12890-023-02394-8.

DOI:10.1186/s12890-023-02394-8
PMID:36978069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10052803/
Abstract

PURPOSE

The clinical characteristics of Klebsiella pneumoniae (KP) pneumonia and KP bloodstream infection (KP-BSI) are often reported, while the risk factors for KP pneumonia developing into secondary KP-BSI (KP-pneumonia/KP-BSI) are largely unknown. Therefore, this study attempted to investigate the clinical characteristics, risk factors and outcomes of KP-pneumonia/KP-BSI.

METHODS

A retrospective observational study was conducted at a tertiary hospital between January 1, 2018, and December 31, 2020. The patients were divided into groups of KP pneumonia alone and KP pneumonia/KP-BSI, and the clinical information were collected from medical records electronic system.

RESULTS

A total of 409 patients were finally recruited. According to the multivariate logistic regression analysis, male sex (adjusted odds ratio [aOR] 3.7; 95% CI, 1.44-9.5), immunosuppression (aOR, 13.52; 95% CI, 2.53,72.22), APACHE II score higher than 21 (aOR, 3.39; 95% CI, 1.41-8.12), serum procalcitonin (PCT) levels above 1.8 ng/ml (aOR, 6.37; 95% CI, 2.67-15.27), ICU stay of more than 2.5 days before pneumonia onset (aOR, 1.09; 95% CI, 1.02,1.17), mechanical ventilation (aOR, 4.96; 95% CI, 1.2,20.5), Klebsiella pneumoniae isolates producing extended spectrum β-lactamase (ESBL-positive KP) (aOR, 12.93; 95% CI, 5.26-31.76), and inappropriate antibacterial therapy (aOR, 12.38; 95% CI, 5.36-28.58) were independent factors of KP pneumonia/KP BSI. In comparison with the patients with KP pneumonia alone, the patients with KP pneumonia/KP BSI showed an almost 3 times higher incidence of septic shock (64.4% vs. 20.1%, p < 0.01), a longer duration of mechanical ventilation, and longer lengths of ICU stay and total hospital stay (median days, 15 vs. 4,19 vs. 6, 34 vs. 17, respectively, both p < 0.01). Additionally, the overall in-hospital crude mortality rate in the patients with KP-pneumonia/KP-BSI was more than two times higher than that in those with KP pneumonia alone (61.5% vs. 27.4%, p < 0.01).

CONCLUSION

Factors including male sex, immunosuppression, APACHE II score higher than 21, serum PCT levels above 1.8 ng/ml, ICU stay of more than 2.5 days before pneumonia onset, mechanical ventilation, ESBL-positive KP, and inappropriate antibacterial therapy are independent risk factors for KP pneumonia/KP-BSI. Of note, the outcomes in patients with KP pneumonia worsen once they develop secondary KP-BSI, which merits more attention.

摘要

目的

肺炎克雷伯菌(KP)肺炎和血流感染(KP-BSI)的临床特征常被报道,而 KP 肺炎发展为继发性 KP-BSI(KP-肺炎/KP-BSI)的危险因素在很大程度上尚不清楚。因此,本研究试图探讨 KP-肺炎/KP-BSI 的临床特征、危险因素和结局。

方法

本研究为 2018 年 1 月 1 日至 2020 年 12 月 31 日在一家三级医院进行的回顾性观察性研究。将患者分为单纯 KP 肺炎组和 KP-肺炎/KP-BSI 组,并从病历电子系统中收集临床信息。

结果

最终共纳入 409 例患者。多因素 logistic 回归分析显示,男性(调整优势比[aOR]3.7;95%CI,1.44-9.5)、免疫抑制(aOR,13.52;95%CI,2.53,72.22)、APACHE II 评分高于 21(aOR,3.39;95%CI,1.41-8.12)、血清降钙素原(PCT)水平高于 1.8ng/ml(aOR,6.37;95%CI,2.67-15.27)、肺炎发病前 ICU 入住时间超过 2.5 天(aOR,1.09;95%CI,1.02,1.17)、机械通气(aOR,4.96;95%CI,1.2,20.5)、产超广谱β-内酰胺酶(ESBL)肺炎克雷伯菌(aOR,12.93;95%CI,5.26-31.76)和抗菌治疗不当(aOR,12.38;95%CI,5.36-28.58)是 KP-肺炎/KP-BSI 的独立危险因素。与单纯 KP 肺炎组相比,KP-肺炎/KP-BSI 组患者发生感染性休克的几率几乎高出 3 倍(64.4%比 20.1%,p<0.01),机械通气时间延长,ICU 入住时间和总住院时间延长(中位数天数,15 比 4,19 比 6,34 比 17,均 p<0.01)。此外,KP-肺炎/KP-BSI 组患者的院内总死亡率是单纯 KP 肺炎组的两倍多(61.5%比 27.4%,p<0.01)。

结论

包括男性、免疫抑制、APACHE II 评分高于 21、血清 PCT 水平高于 1.8ng/ml、肺炎发病前 ICU 入住时间超过 2.5 天、机械通气、产 ESBL 肺炎克雷伯菌和抗菌治疗不当是 KP-肺炎/KP-BSI 的独立危险因素。值得注意的是,KP 肺炎患者一旦发生继发性 KP-BSI,病情会恶化,这值得更多关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e3/10052803/5d803238b8f0/12890_2023_2394_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e3/10052803/b6fa5ddbed79/12890_2023_2394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e3/10052803/5d803238b8f0/12890_2023_2394_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e3/10052803/b6fa5ddbed79/12890_2023_2394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3e3/10052803/5d803238b8f0/12890_2023_2394_Fig2_HTML.jpg

相似文献

1
Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.肺炎克雷伯菌肺炎发展为继发性肺炎克雷伯菌血流感染的临床特征、危险因素和结局。
BMC Pulm Med. 2023 Mar 28;23(1):102. doi: 10.1186/s12890-023-02394-8.
2
Risk factors of community-onset extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia in South Korea using national health insurance claims data.使用国家健康保险索赔数据对韩国社区获得性产Extended-spectrum β-lactamase 肺炎克雷伯菌菌血症的危险因素进行分析。
Int J Antimicrob Agents. 2019 Dec;54(6):723-727. doi: 10.1016/j.ijantimicag.2019.09.005. Epub 2019 Sep 11.
3
[Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].[超广谱β-内酰胺酶对肺炎克雷伯菌血流感染患者临床结局及医疗费用的影响]
Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1903-6. doi: 10.3760/cma.j.issn.0376-2491.2016.24.006.
4
Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.2014-2018 年中国大型三级医院血流感染肺炎克雷伯菌的危险因素和死亡率:碳青霉烯类耐药的临床影响。
J Infect Public Health. 2020 May;13(5):784-790. doi: 10.1016/j.jiph.2019.11.014. Epub 2019 Dec 13.
5
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.产 ESBL 大肠埃希菌和产 ESBL 肺炎克雷伯菌血流感染的预测因素及死亡率比较。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):660-667. doi: 10.1017/ice.2018.63. Epub 2018 Apr 5.
6
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.同一流行都市地区医院内耐碳青霉烯类肺炎克雷伯菌血流感染的流行病学、管理和结局。
J Infect Public Health. 2018 Mar-Apr;11(2):171-177. doi: 10.1016/j.jiph.2017.06.003. Epub 2017 Jun 28.
7
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Bloodstream Infections.多微生物血流感染患者的临床特征、危险因素和结局。
Biomed Res Int. 2021 Jun 19;2021:6619911. doi: 10.1155/2021/6619911. eCollection 2021.
8
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌所致血流感染的危险因素:重点关注包括头孢吡肟在内的抗菌药物。
Am J Infect Control. 2015 Jul 1;43(7):719-23. doi: 10.1016/j.ajic.2015.02.030. Epub 2015 Apr 29.
9
Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.老年耐碳青霉烯类肺炎克雷伯菌血流感染患者的危险因素和死亡率:一项 10 年纵向研究。
BMC Geriatr. 2022 Jul 13;22(1):573. doi: 10.1186/s12877-022-03275-1.
10
Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.华北地区一家三甲医院碳青霉烯类耐药肺炎克雷伯菌血流感染的流行率和感染及死亡危险因素的 5 年变化。
Antimicrob Resist Infect Control. 2020 Jun 1;9(1):79. doi: 10.1186/s13756-020-00728-3.

引用本文的文献

1
Clinical Characteristics and Independent Risk Factors for Multidrug-Resistant Bloodstream Infections: A Retrospective Analysis from China.耐多药血流感染的临床特征及独立危险因素:一项来自中国的回顾性分析
Infect Drug Resist. 2025 Aug 10;18:3993-4006. doi: 10.2147/IDR.S535018. eCollection 2025.
2
Carbapenem-resistant bacteria in the environment.环境中的耐碳青霉烯类细菌。
Arh Hig Rada Toksikol. 2025 Jun 30;76(2):87-101. doi: 10.2478/aiht-2025-76-3956. eCollection 2025 Jun 1.
3
Antibiotic resistance in empyema thoracis: clinical outcomes and contributing factors in a tertiary care setting in Pakistan.

本文引用的文献

1
Clinical Epidemiology, Risk Factors, and Control Strategies of Infection.感染的临床流行病学、危险因素及控制策略
Front Microbiol. 2021 Dec 22;12:750662. doi: 10.3389/fmicb.2021.750662. eCollection 2021.
2
Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌所致重症监护病房获得性肺炎患者继发性血流感染的临床特征及危险因素
Chin Med J (Engl). 2021 Jul 20;134(14):1735-1737. doi: 10.1097/CM9.0000000000001444.
3
Clinical features and development of Sepsis in Klebsiella pneumoniae infected liver abscess patients: a retrospective analysis of 135 cases.
脓胸的抗生素耐药性:巴基斯坦一家三级医疗机构的临床结果及相关因素
IJID Reg. 2025 Apr 30;15:100658. doi: 10.1016/j.ijregi.2025.100658. eCollection 2025 Jun.
4
Dual threat: Susceptibility mechanisms and treatment strategies for COVID-19 and bacterial co-infections.双重威胁:新型冠状病毒肺炎与细菌合并感染的易感性机制及治疗策略
Comput Struct Biotechnol J. 2025 May 22;27:2107-2122. doi: 10.1016/j.csbj.2025.05.033. eCollection 2025.
5
Research and predictive analysis of the disease burden of bloodstream infectious diseases in China.中国血流感染性疾病疾病负担的研究与预测分析
BMC Infect Dis. 2025 Apr 22;25(1):578. doi: 10.1186/s12879-025-10989-1.
6
Phage-antibiotic combinations against : impact of methodological approaches on effect evaluation.噬菌体-抗生素联合疗法:方法学途径对疗效评估的影响
Front Microbiol. 2025 Mar 12;16:1530819. doi: 10.3389/fmicb.2025.1530819. eCollection 2025.
7
The Inhibitory Effects of ARA301 Extract on Lipopolysaccharide-Induced Lung Injury .ARA301提取物对脂多糖诱导的肺损伤的抑制作用
J Microbiol Biotechnol. 2025 Mar 6;35:e2412043. doi: 10.4014/jmb.2412.12043.
8
Varicella challenges: A case of respiratory tract complications in an elderly patient.水痘引发的挑战:一例老年患者的呼吸道并发症病例
Narra J. 2024 Dec;4(3):e1150. doi: 10.52225/narra.v4i3.1150. Epub 2024 Nov 1.
9
Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes.成年患者肺炎克雷伯菌复合种血流感染:不断变化的流行病学及不良预后的决定因素
Infection. 2025 Jan 2. doi: 10.1007/s15010-024-02457-w.
10
Anti-quorum sensing activity of essential oils against multidrug-resistant Klebsiella pneumoniae: a novel approach to control bacterial virulence.精油对多重耐药肺炎克雷伯菌的群体感应抑制活性:一种控制细菌毒力的新方法。
Braz J Microbiol. 2024 Dec;55(4):3909-3920. doi: 10.1007/s42770-024-01546-0. Epub 2024 Oct 30.
肺炎克雷伯菌肝脓肿患者脓毒症的临床特征及转归:135 例回顾性分析。
BMC Infect Dis. 2021 Jun 23;21(1):597. doi: 10.1186/s12879-021-06325-y.
4
Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia.美国医院中,耐碳青霉烯革兰氏阴性菌引起的尿路感染(无论是否伴有菌血症)导致的疾病负担。
BMC Infect Dis. 2021 Jun 14;21(1):572. doi: 10.1186/s12879-021-06229-x.
5
Clinical Observation and Prognostic Analysis of Patients With Bloodstream Infection.血流感染患者的临床观察与预后分析。
Front Cell Infect Microbiol. 2020 Nov 9;10:577244. doi: 10.3389/fcimb.2020.577244. eCollection 2020.
6
Extensively-Drug Resistant Recovered From Neonatal Sepsis Cases From a Major NICU in Egypt.从埃及一家大型新生儿重症监护病房的新生儿败血症病例中分离出的广泛耐药菌。
Front Microbiol. 2020 Jun 19;11:1375. doi: 10.3389/fmicb.2020.01375. eCollection 2020.
7
presents antimicrobial drug resistance for β-lactam through the ESBL/PBP signaling pathway.通过ESBL/PBP信号通路呈现β-内酰胺类抗菌药物耐药性。
Exp Ther Med. 2020 Apr;19(4):2449-2456. doi: 10.3892/etm.2020.8498. Epub 2020 Feb 7.
8
Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.成人社区获得性肺炎的诊断与治疗
JAMA. 2020 Mar 3;323(9):885-886. doi: 10.1001/jama.2019.21118.
9
Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections.混合性肠球菌血流感染的临床特征及危险因素
Infect Drug Resist. 2019 Oct 31;12:3397-3407. doi: 10.2147/IDR.S217905. eCollection 2019.
10
Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla, virulence factors and their impacts on clinical outcome.肺炎克雷伯菌血流感染:bla 的流行情况、毒力因子及其对临床结局的影响。
BMC Infect Dis. 2018 Jul 31;18(1):358. doi: 10.1186/s12879-018-3263-x.